Endometrial ablation using a distensible multielectrode balloon: a long‐term follow‐up report

Abstract

Objective To present long term follow up data on patients treated at The Royal Surrey County Hospital, who took part in an evaluation study of the Vesta™ system. Study design A prospective follow‐up study at 3.5–5 years following treatment. Subjects and methods Twenty‐five patients were asked to complete a questionnaire detailing their medical history since the initial Vesta™ system procedure, together with a validated pictorial blood loss assessment chart. A life table analysis of the patients enrolled into the European study was also carried out at 2 years. Results Of the 25 patients, a TCRE had to be carried out as a second operation in two patients because of continuing menorrhagia, and one patient had a pictorial blood loss score of >150 but did not want further treatment at 5 years. Therefore, treatment with the Vesta™ system failed to relieve the original symptoms or avoid second surgery in 3/25 (12%) of the patients in the long term. Life table analysis of the patients enrolled into the European study has demonstrated a failure rate of 11% at 2 years. Conclusion Our long term results suggest that the efficacy of the Vesta™ System at 2 years persists at 3.5–5 years following treatment.

Menorrhagia: the role of endometrial ablation

“…It consists of a polymer balloon covered with 12 monopolar electrodes inflated within the uterine cavity to bring the electrodes into contact with the endometrium for a treatment time of 4-7 min. Non-randomised clinical studies suggest that similar amenorrhoea and success rates to FEAT can be expected [35,36].…”